Serum Levels of Coll2-1, a Specific Biomarker of Cartilage Degradation, Are Not Affected by Sampling Conditions, Circadian Rhythm, and Seasonality

• Published in: Cartilage Vol. 13; no. 1_suppl; pp. 540S - 549S
• Main Authors: Hick, Anne-Christine, Fonck, Misch, Costes, Bérénice, Cobraiville, Elisabeth, Pirson, Sébastien, Garcia, Laetitia, Labasse, Alain, Vander Poelen, Steven, Henrotin, Yves
• Format: Journal Article Web Resource
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.12.2021
• Subjects: biomarkers; cartilage; Clinical Research papers; clinical study; Human health sciences; knee; osteoarthritis; Rheumatology; Rhumatologie; Sciences de la santé humaine; clinical study; knee; osteoarthritis; biomarkers; cartilage
• ISSN: 1947-6035; 1947-6043; 1947-6043
• DOI: 10.1177/1947603519878489

Objective: To assess intraindividual biological variability of serum cartilage specific biomarker Coll2-1 and define the best standardized conditions for blood sampling. Design: Blood samples were taken from 116 subjects with knee osteoarthritis (OA) at a single time point (PRODIGE study) and from 15 healthy subjects under various conditions, including fasting condition, sampling time and season, blood treatment, and type of blood collection tube (COVAR study). Type II collagen-specific biomarker Coll2-1 was directly measured in serum using an immunoassay. Results: There was no significant difference on Coll2-1 values between samples collected at any of the 5 sampling times or at any of the sampling days measured. None of the sampling parameters tested had a significant impact on Coll2-1 value (clotting time, clotting temperature and temperature of blood centrifugation, type of tube). On the contrary, differences were found in between subjects and between subjects with knee OA and healthy subjects. Conclusion: Coll2-1 measurement is not affected by sampling specific conditions, circadian rhythm or seasons but was found elevated in subject with knee OA indicating that Coll2-1 serum variation is not linked to the study environment, but to cartilage degradation in OA. Coll2-1 assay is sufficiently robust for use in OA clinical trials.